23 research outputs found
Studies on barley malt kernel heterogeneity
Standard analysis of malt flour can mask the heterogeneity of hydrolytic enzyme
activity. Kernel heterogeneity can lead to brewhouse problems and a product
with unpredictable nitrogen and fermentable sugar content. The variability
between individual grains of important malting characteristics was measured in
malt samples produced under aerobic and anaerobic conditions.
Various parameters (including germinative energy, germinative capacity,
moisture content, ÎČ-glucanase activity, friability and homogeneity) were
measured to ensure that the 5 d aerobic Optic malt, produced in Heriot-Watt
university micromaltings, was viable and of commercial quality.
The 5 d aerobic malt kernels produced at Simpsons Maltings in Berwick-Upon-
Tweed were heavier than the micromalt. Commercially produced malt kernels
had higher levels of fermentable sugars and soluble nitrogen than the micromalt
despite lower α-amylase, ÎČ-amylase and âtotalâ limit dextrinase activity.
Differences between the 5 d aerobic micromalt and the 5 d aerobic
commercially produced malt are indicative of why micromalting cannot always
be used as a model system for what is happening industrially and must be
modelled on commercial practice.
Subjecting 5 d aerobic micromalt to 24 h anaerobic incubation resulted in
increased levels of fermentable sugars per l wort. 24 h anoxia also resulted in
increased α-amylase and limit dextrinase activities. There are potential
industrial applications for this anaerobic wort.
Limit dextrinase inhibitor protein present in crude extract prepared from mature
barley, eluted from a gel filtration column at a higher molecular weight than
expected. The limit dextrinase inhibitor protein either aggregates or binds to
other proteins in a high molecular weight complex.International Centre for Brewing and Distilling (ICBD)Lindisfarne Trus
Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans.
BACKGROUND: The COVID-19 pandemic has disrupted routine hospital services globally. This study estimated the total number of adult elective operations that would be cancelled worldwide during the 12âweeks of peak disruption due to COVID-19. METHODS: A global expert response study was conducted to elicit projections for the proportion of elective surgery that would be cancelled or postponed during the 12âweeks of peak disruption. A Bayesian ÎČ-regression model was used to estimate 12-week cancellation rates for 190 countries. Elective surgical case-mix data, stratified by specialty and indication (surgery for cancer versus benign disease), were determined. This case mix was applied to country-level surgical volumes. The 12-week cancellation rates were then applied to these figures to calculate the total number of cancelled operations. RESULTS: The best estimate was that 28â404â603 operations would be cancelled or postponed during the peak 12âweeks of disruption due to COVID-19 (2â367â050 operations per week). Most would be operations for benign disease (90·2 per cent, 25â638â922 of 28â404â603). The overall 12-week cancellation rate would be 72·3 per cent. Globally, 81·7 per cent of operations for benign conditions (25â638â922 of 31â378â062), 37·7 per cent of cancer operations (2â324â070 of 6â162â311) and 25·4 per cent of elective caesarean sections (441â611 of 1â735â483) would be cancelled or postponed. If countries increased their normal surgical volume by 20 per cent after the pandemic, it would take a median of 45âweeks to clear the backlog of operations resulting from COVID-19 disruption. CONCLUSION: A very large number of operations will be cancelled or postponed owing to disruption caused by COVID-19. Governments should mitigate against this major burden on patients by developing recovery plans and implementing strategies to restore surgical activity safely
Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery
Peer reviewe
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28â2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65â3·22], p\textless0·0001), American Society of Anesthesiologists grades 3â5 versus grades 1â2 (2·35 [1·57â3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01â2·39], p=0·046), emergency versus elective surgery (1·67 [1·06â2·63], p=0·026), and major versus minor surgery (1·52 [1·01â2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study
AIM: The SARS-CoV-2 pandemic has provided a unique opportunity to explore the impact of surgical delays on cancer resectability. This study aimed to compare resectability for colorectal cancer patients undergoing delayed versus non-delayed surgery. METHODS: This was an international prospective cohort study of consecutive colorectal cancer patients with a decision for curative surgery (January-April 2020). Surgical delay was defined as an operation taking place more than 4âweeks after treatment decision, in a patient who did not receive neoadjuvant therapy. A subgroup analysis explored the effects of delay in elective patients only. The impact of longer delays was explored in a sensitivity analysis. The primary outcome was complete resection, defined as curative resection with an R0 margin. RESULTS: Overall, 5453 patients from 304 hospitals in 47 countries were included, of whom 6.6% (358/5453) did not receive their planned operation. Of the 4304 operated patients without neoadjuvant therapy, 40.5% (1744/4304) were delayed beyond 4âweeks. Delayed patients were more likely to be older, men, more comorbid, have higher body mass index and have rectal cancer and early stage disease. Delayed patients had higher unadjusted rates of complete resection (93.7% vs. 91.9%, PÂ =Â 0.032) and lower rates of emergency surgery (4.5% vs. 22.5%, Pâ<â0.001). After adjustment, delay was not associated with a lower rate of complete resection (OR 1.18, 95% CI 0.90-1.55, PÂ =Â 0.224), which was consistent in elective patients only (OR 0.94, 95% CI 0.69-1.27, PÂ =Â 0.672). Longer delays were not associated with poorer outcomes. CONCLUSION: One in 15 colorectal cancer patients did not receive their planned operation during the first wave of COVID-19. Surgical delay did not appear to compromise resectability, raising the hypothesis that any reduction in long-term survival attributable to delays is likely to be due to micro-metastatic disease
Studies on barley malt kernel heterogeneity
Standard analysis of malt flour can mask the heterogeneity of hydrolytic enzyme activity. Kernel heterogeneity can lead to brewhouse problems and a product with unpredictable nitrogen and fermentable sugar content. The variability between individual grains of important malting characteristics was measured in malt samples produced under aerobic and anaerobic conditions. Various parameters (including germinative energy, germinative capacity, moisture content, ÎČ-glucanase activity, friability and homogeneity) were measured to ensure that the 5 d aerobic Optic malt, produced in Heriot-Watt university micromaltings, was viable and of commercial quality. The 5 d aerobic malt kernels produced at Simpsons Maltings in Berwick-Upon- Tweed were heavier than the micromalt. Commercially produced malt kernels had higher levels of fermentable sugars and soluble nitrogen than the micromalt despite lower α-amylase, ÎČ-amylase and âtotalâ limit dextrinase activity. Differences between the 5 d aerobic micromalt and the 5 d aerobic commercially produced malt are indicative of why micromalting cannot always be used as a model system for what is happening industrially and must be modelled on commercial practice. Subjecting 5 d aerobic micromalt to 24 h anaerobic incubation resulted in increased levels of fermentable sugars per l wort. 24 h anoxia also resulted in increased α-amylase and limit dextrinase activities. There are potential industrial applications for this anaerobic wort. Limit dextrinase inhibitor protein present in crude extract prepared from mature barley, eluted from a gel filtration column at a higher molecular weight than expected. The limit dextrinase inhibitor protein either aggregates or binds to other proteins in a high molecular weight complex.EThOS - Electronic Theses Online ServiceInternational Centre for Brewing and Distilling (ICBD) : Lindisfarne TrustGBUnited Kingdo
Les Bostrichidae Latreille, 1802 de la faune de France : espĂšces autochtones, interceptĂ©es, introduites ou susceptibles de l'ĂȘtre (Coleoptera)
Catalogue actualisé et commenté des ColéoptÚres Bostrichidae de la faune de France continentale et de Corse. (Résumé d'auteur
COVID-19-related absence among surgeons : development of an international surgical workforce prediction model
Background: During the initial COVID-19 outbreak up to 28.4 million elective operations were cancelled worldwide, in part owing to concerns that it would be unsustainable to maintain elective surgery capacity because of COVID-19-related surgeon absence. Although many hospitals are now recovering, surgical teams need strategies to prepare for future outbreaks. This study aimed to develop a framework to predict elective surgery capacity during future COVID-19 outbreaks.
Methods: An international cross-sectional study determined real-world COVID-19-related absence rates among surgeons. COVID-19-related absences included sickness, self-isolation, shielding, and caring for family. To estimate elective surgical capacity during future outbreaks, an expert elicitation study was undertaken with senior surgeons to determine the minimum surgical staff required to provide surgical services while maintaining a range of elective surgery volumes (0, 25, 50 or 75 per cent).
Results: Based on data from 364 hospitals across 65 countries, the COVID-19-related absence rate during the initial 6 weeks of the outbreak ranged from 20.5 to 24.7 per cent (mean average fortnightly). In weeks 7-12, this decreased to 9.2-13.8 per cent. At all times during the COVID-19 outbreak there was predicted to be sufficient surgical staff available to maintain at least 75 per cent of regular elective surgical volume. Overall, there was predicted capacity for surgeon redeployment to support the wider hospital response to COVID-19.
Conclusion: This framework will inform elective surgical service planning during future COVID-19 outbreaks. In most settings, surgeon absence is unlikely to be the factor limiting elective surgery capacity
How frequent is routine use of probiotics in UK neonatal units?
Objective There is a lack of UK guidance regarding routine use of probiotics in preterm infants to prevent necrotising enterocolitis, late-onset sepsis and death. As practices can vary, we aimed to determine the current usage of probiotics within neonatal units in the UK.Design and setting Using NeoTRIPS, a trainee-led neonatal research network, an online survey was disseminated to neonatal units of all service levels within England, Scotland, Northern Ireland and Wales in 2022. Trainees were requested to complete one survey per unit regarding routine probiotic administration.Results 161 of 188 (86%) neonatal units responded to the survey. 70 of 161 (44%) respondents routinely give probiotics to preterm infants. 45 of 70 (64%) use the probiotic product Lactobacillus acidophilus NCFM/Bifidobacterium bifidum Bb-06/B. infantis Bi-26 (Labinicâą). 57 of 70 (81%) start probiotics in infants â€32 weeksâ gestation. 33 of 70 (47%) had microbiology departments that were aware of the use of probiotics and 64 of 70 (91%) had a guideline available. Commencing enteral feeds was a prerequisite to starting probiotics in 62 of 70 (89%) units. The majority would stop probiotics if enteral feeds were withheld (59 of 70; 84%) or if the infant was being treated for necrotising enterocolitis (69 of 70; 99%). 24 of 91 (26%) units that did not use probiotics at the time of the survey were planning to introduce them within the next 12 months.Conclusions More than 40% of all UK neonatal units that responded are now routinely administering probiotics, with variability in the product used. With increased probiotic usage in recent years, there is a need to establish whether this translates to improved clinical outcomes